In AD patients, both total tau protein (t-tau) and phosphorylated tau protein (p-tau) levels are related to neuronal degeneration and tau tangle pathology, so raised levels of t-tau and p-tau in CSF are the diagnostic variations of AD (Constantinescu and Mondello, 2013). The gene discussed is MAPT; the disease is Alzheimer disease.